Dosimetry Flashcards

1
Q

What is in-vivo dosimetry?

A

Taking measurements of the dos actually delivered to the patient at treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why do in-vivo dosimetry?

A

Safeguard against significant errors
Function as check of entire treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Point dose measurement

A

Measure dose at a point, using TLDs or diodes (traditionally)
Detectors placed on patient skin, entry/exit dose measured
Must not perturb beam
Only meaningful in uniform dose region: best for conformal treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Limitations of point dose measurement

A

Devices require calibration and maintenance
Require placement at each fraction
How do you verify it was in the correct place if it’s out of tolerance?
Not suitable for VMAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Advantages of TLD for point dose measurement

A

No temperature dependence
No dose rate dependence
No directional dependence
No wires

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Disadvantages of TLD for point dose measurement

A

Specialised reader and annealing device necessary
Fiddly to handle
No real time read out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Advantages of diodes for point dose measurement

A

High sensitivity allows high spatial resolution
Easier to handle than TLDs
Immediately available for re-use
Real time read out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Disadvantages of diodes for point dose measurement

A

Connection with wire
Temperature, dose rate, directionally, field size dependent
Correction factors needed as a result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EPID for IVD

A

Full 2D map of dose can be obtained, more suitable for IMRT and VMAT
Response is energy dependent and corrections are therefore required
Size and position of EPID can limit use, need couch clearance, might sag which needs correction, might not get data needed from linac

Is exit dose, so patient set up problems can be identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Forward projection EPID

A

Grayscale distribution measured with EID compared with predicted value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Back projection EPID

A

Measured fluence at PID back projected through CT data to calculated 3D dose in patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Log files

A

Look at trajectory log files produced by linac, tells you gantry position etc
Can confirm if they are as expected
Relies on them being correct
No information regarding patient - is this in-vivo?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Transmission detector

A

Detector mounted on gantry head which measures delivery
Perturbs treatment field - does it need modelling?
No information regarding patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What errors can be captured with in vivo?

A

What can be detected depends on type of in-vivo used

Machine related errors (MLC position, collimator angle, beam flatness..)
Plan related errors (errors in dose calculation, delivery of incorrect plan..)
Patient related errors (anatomical changes, positioning errors, movement..)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What can’t be detected with in-vivo?

A

Problems common to plan and in-vivo system (data transfer, wrong patient dose, wrong plan)
Problems inside tolerance values or difficult to understand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What else do we do alongside in-vivo?

A

Independent plan check calculations
Pre treatment QA
Machine and TPS QA
Electronic transfer of data
R&V systems
Machine interlocks
Dose audits
Staff training
Reporting of errors

17
Q

Why is response energy dependent for EPID and how do we correct for this?

A

High atomic number in buildup and scintillation layers means response increases with decreasing energy (PE)
Change in response off axis as energy changes due to FF
Field size dependent as scatter changes
Attenuation by patient alters beam energy
Corrections therefore required by flood field images, look up tables, model based corrections

18
Q

What are the effects of a transmission detector perturbing the treatment field?

A

Beam hardening and scatter
Increased skin dose
Beam attenuation
May need to model in TPS to account for this